VennVax, a DNA-prime, peptide-boost multi-T-cell epitope poxvirus vaccine, induces protective immunity against vaccinia infection by T cell response alone.
about
Application of IgG-derived natural Treg epitopes (IgG Tregitopes) to antigen-specific tolerance induction in a murine model of type 1 diabetesPost-Genomics and Vaccine Improvement for LeishmaniaSide-by-side comparison of gene-based smallpox vaccine with MVA in nonhuman primatesMaking vaccines "on demand": a potential solution for emerging pathogens and biodefense?Cross-conservation of T-cell epitopes: now even more relevant to (H7N9) influenza vaccine design.HIV-1 Vaccine Trials: Evolving Concepts and DesignsPartial pathogen protection by tick-bite sensitization and epitope recognition in peptide-immunized HLA DR3 transgenic mice.HelicoVax: epitope-based therapeutic Helicobacter pylori vaccination in a mouse modelCHOPPI: a web tool for the analysis of immunogenicity risk from host cell proteins in CHO-based protein production.Polyclonal antibody cocktails generated using DNA vaccine technology protect in murine models of orthopoxvirus disease.Development and validation of an epitope prediction tool for swine (PigMatrix) based on the pocket profile methodAn immunoinformatic approach for identification of Trypanosoma cruzi HLA-A2-restricted CD8(+) T cell epitopes.A vaccinia virus renaissance: new vaccine and immunotherapeutic uses after smallpox eradication.Time for T? Immunoinformatics addresses vaccine design for neglected tropical and emerging infectious diseasesOptimizing vaccine development.New vaccines needed for pathogens infecting animals and humans: One Health.Accelerated vaccine development against emerging infectious diseases.Defending against smallpox: a focus on vaccines.Preclinical development of HIvax: Human survivin highly immunogenic vaccinesAn immunoinformatics-derived DNA vaccine encoding human class II T cell epitopes of Ebola virus, Sudan virus, and Venezuelan equine encephalitis virus is immunogenic in HLA transgenic mice.iVAX: An integrated toolkit for the selection and optimization of antigens and the design of epitope-driven vaccines.A comparison of two methods for T cell epitope mapping: "cell free" in vitro versus immunoinformatics.Immunogenicity of Therapeutic Fusion Proteins: Contributory Factors and Clinical ExperienceMovingHelicobacter pylorivaccine development forward with bioinformatics and immunomicsTools for Vaccine Design: Prediction and Validation of Highly Immunogenic and Conserved Class II Epitopes and Development of Epitope-Driven Vaccines
P2860
Q24627149-2F288B47-5017-4038-9751-CD14C61D2BC0Q26752532-83F5DF28-BA68-463E-88CF-AF595AAB230EQ27325586-C3E94C62-25BE-42BE-98A4-83B0CAAF65ECQ30222126-2F716BC2-2FE1-417C-9156-01A459BFB797Q30358954-B37C4517-07E9-4FF7-A646-2991CCDC9556Q30425520-8BBE837C-F74C-47BC-AC90-0FAF5347B9C4Q33723303-20B9FCE5-DC07-4911-BD6E-2DDDDCAFA09BQ34612386-A3D80251-6748-46AC-B3B6-A3A713CE3EC9Q34803518-7694036E-967C-46AE-BC3B-AD10E62142D3Q35339702-0D58D26A-E4E2-44ED-B399-72272491CCC6Q35775321-50C474D2-5864-4B1F-82E8-11C48CBAEB2DQ36256258-77A0E72F-4C5E-4036-8F92-07EBABDD8553Q36391900-AAA56376-8782-4544-A8BC-5E8CB80173BBQ36550981-880E91A6-6486-4471-BF11-CB226BB65813Q37883493-86102333-AC2B-41E5-A054-3084D54DE49CQ38000986-4B26B7D4-3160-41A4-A28D-203542840E38Q38024964-55802FC0-B5ED-4C90-8FBF-9C77DBFEFCE8Q38799357-40E19CCF-8AC7-4D09-8E15-C2FF9CEA6BC3Q38867680-DD4A6145-543C-45D8-B434-91ECE40B474BQ40054259-F2D2EE2C-D22C-42EF-951F-7F62DB3F8D07Q41117694-D6DB8115-9760-47AE-A393-D5CFC87AA3C5Q42066714-3E0E6784-F45B-4350-858F-2F404A003FB1Q57537530-CDB59927-1F8E-44FD-BEFA-3827DF232B57Q57537553-3FE38B89-193F-4827-8803-9F0DC96C0714Q57537566-FAD5130F-18AA-4632-9D04-172030159466
P2860
VennVax, a DNA-prime, peptide-boost multi-T-cell epitope poxvirus vaccine, induces protective immunity against vaccinia infection by T cell response alone.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
VennVax, a DNA-prime, peptide- ...... tion by T cell response alone.
@ast
VennVax, a DNA-prime, peptide- ...... tion by T cell response alone.
@en
type
label
VennVax, a DNA-prime, peptide- ...... tion by T cell response alone.
@ast
VennVax, a DNA-prime, peptide- ...... tion by T cell response alone.
@en
prefLabel
VennVax, a DNA-prime, peptide- ...... tion by T cell response alone.
@ast
VennVax, a DNA-prime, peptide- ...... tion by T cell response alone.
@en
P2093
P2860
P1433
P1476
VennVax, a DNA-prime, peptide- ...... tion by T cell response alone.
@en
P2093
David B Weiner
Jill Schriewer
Jinhee Lee
R Mark Buller
Sharon E Frey
William Martin
P2860
P304
P356
10.1016/J.VACCINE.2010.10.064
P407
P577
2010-11-04T00:00:00Z